A prior study by Jang and associates demonstrated in in vivo models of dry AMD that a RIPK1 inhibitor possesses a protective effect on RPE cells through fundus evaluation and electroretinogram analyses, assessing effective retinal penetration and prevention of retinal degeneration in dry AMD [481]. This evidence concerns the gene RIPK1 and dry age related macular degeneration.